多发性硬化症的细胞免疫疗法:机制性见解和临床进展
Vasily Kurilin1, Marina Fisher1, Irina Obleukhova1
1Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), Novosibirsk 630099, Russia.
International journal of molecular sciences
|January 28, 2026
概括
多发性硬化症是一种影响中枢神经系统的免疫媒介疾病. 本综述探讨了针对多发性硬化症病原体中的免疫细胞的细胞免疫疗法.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 多发性硬化症 (MS) 是一种慢性,免疫媒介的神经退行性疾病,影响中枢神经系统 (CNS),影响劳动年龄人口.
- 在病理上,MS的特点是大脑和脊髓中的脱髓化病变,导致神经元受到T细胞,B细胞和髓状细胞等自身攻击性免疫因子的损伤.
- 免疫细胞透到中枢神经系统会导致焦点病变和组织损伤,由于治疗成本和就业问题,这带来了重大的社会和经济挑战.
研究的目的:
- 审查目前对多发性硬化症细胞免疫疗法方法的理解.
- 讨论在MS免疫病原发生过程中调节细胞免疫反应的方法.
主要方法:
- 文献综述专注于多发性硬化症细胞免疫疗法.
- 对调查免疫细胞参与多发性硬化症发病的研究进行分析.
- 综合了针对细胞免疫的新型治疗策略的信息.
主要成果:
- 诊断方面的进步使得MS的早期检测和免疫校正成为可能.
- 新型向和细胞免疫疗法正在积极开发用于MS治疗.
- 细胞免疫疗法为影响多发性硬化症免疫病原发生提供了有希望的途径.
结论:
- 细胞免疫疗法是治疗多发性硬化症的关键研究领域.
- 准参与中枢神经系统损伤的免疫细胞是一个可行的治疗策略.
- 对细胞免疫疗法的进一步研究有可能改善MS患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
01:49Multiple Allele Traits
38.1K
The Concept of Multiple Allelism
38.1K
01:21Mechanistic Models: Overview of Compartment Models
373
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
373
02:22Overview of Advanced Functional Groups
29.7K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.7K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
260
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
260